Literature DB >> 17401523

Functional outcome after severe cerebral venous thrombosis.

Andreas Bender1, Gernot Schulte-Altedorneburg, Thomas E Mayer, Thomas Pfefferkorn, Tobias Birnbaum, Berend Feddersen, Hartmut Brückmann, Hans-Walter Pfister, Andreas Straube.   

Abstract

Severe cerebral venous thrombosis (CVT) is a rare cerebrovascular condition which in the more severe cases warrants intensive care treatment. While the outcome in the majority of uncomplicated CVT cases is good, it may be fatal in more affected patients. We provide long-term functional and quality of life (QOL) outcome data in the form of a retrospective analysis of 10 patients admitted to a neurological ICU with severe CVT. Outcome measures used were the modified Rankin Scale, the 36-item Short Form Health Survey, and the Psychological General Well-Being index. The mortality rate was 50% but 4 out 5 survivors had a good functional outcome with normal QOL despite a very severe clinical course. This finding justifies extensive life-sustaining therapy as the prognosis even of severe cases may be good if the acute phase is survived.

Entities:  

Mesh:

Year:  2007        PMID: 17401523     DOI: 10.1007/s00415-006-0391-9

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  16 in total

1.  Cerebral venous thrombosis: clinical outcome and systematic screening of prothrombotic factors.

Authors:  S Cakmak; L Derex; M Berruyer; N Nighoghossian; F Philippeau; P Adeleine; M Hermier; J C Froment; P Trouillas
Journal:  Neurology       Date:  2003-04-08       Impact factor: 9.910

2.  Causes and predictors of death in cerebral venous thrombosis.

Authors:  Patrícia Canhão; José M Ferro; Arne G Lindgren; Marie-Germaine Bousser; Jan Stam; Fernando Barinagarrementeria
Journal:  Stroke       Date:  2005-07-07       Impact factor: 7.914

3.  Experimental cerebral venous thrombosis: evaluation using magnetic resonance imaging.

Authors:  J Röther; K Waggie; N van Bruggen; A J de Crespigny; M E Moseley
Journal:  J Cereb Blood Flow Metab       Date:  1996-11       Impact factor: 6.200

4.  Long-term outcome of cognition and functional health after cerebral venous sinus thrombosis.

Authors:  S F de Bruijn; M Budde; S Teunisse; R J de Haan; J Stam
Journal:  Neurology       Date:  2000-04-25       Impact factor: 9.910

5.  Occlusion of the pig superior sagittal sinus, bridging and cortical veins: multistep evolution of sinus-vein thrombosis.

Authors:  G Fries; T Wallenfang; J Hennen; M Velthaus; A Heimann; H Schild; A Perneczky; O Kempski
Journal:  J Neurosurg       Date:  1992-07       Impact factor: 5.115

6.  Experimental study of venous circulatory disturbance by dural sinus occlusion.

Authors:  M Gotoh; T Ohmoto; H Kuyama
Journal:  Acta Neurochir (Wien)       Date:  1993       Impact factor: 2.216

7.  Prognosis of cerebral vein and dural sinus thrombosis: results of the International Study on Cerebral Vein and Dural Sinus Thrombosis (ISCVT).

Authors:  José M Ferro; Patrícia Canhão; Jan Stam; Marie-Germaine Bousser; Fernando Barinagarrementeria
Journal:  Stroke       Date:  2004-02-19       Impact factor: 7.914

8.  Long-term prognosis in cerebral venous thrombosis. Follow-up of 77 patients.

Authors:  M Preter; C Tzourio; A Ameri; M G Bousser
Journal:  Stroke       Date:  1996-02       Impact factor: 7.914

9.  Influence of recanalization on outcome in dural sinus thrombosis: a prospective study.

Authors:  Erwin Stolz; Susan Trittmacher; Anousha Rahimi; Tibo Gerriets; Carina Röttger; Ralf Siekmann; Manfred Kaps
Journal:  Stroke       Date:  2004-01-08       Impact factor: 7.914

10.  Cerebral venous thrombosis 3-year clinical outcome in 55 consecutive patients.

Authors:  G Breteau; F Mounier-Vehier; O Godefroy; J-Y Gauvrit; M-A Mackowiak-Cordoliani; M Girot; D Bertheloot; H Hénon; C Lucas; X Leclerc; F Fourrier; J P Pruvo; D Leys
Journal:  J Neurol       Date:  2003-01       Impact factor: 4.849

View more
  1 in total

1.  Noncontrast CT in deep cerebral venous thrombosis and sinus thrombosis: comparison of its diagnostic value for both entities.

Authors:  J Linn; T Pfefferkorn; K Ivanicova; S Müller-Schunk; S Hartz; M Wiesmann; M Dichgans; H Brückmann
Journal:  AJNR Am J Neuroradiol       Date:  2009-02-12       Impact factor: 3.825

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.